Trials / Conditions / Pervasive Developmental Disorder

Pervasive Developmental Disorder

25 registered clinical trials studyying Pervasive Developmental Disorder — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	The Impact of a Virtual Magic Trick Training Program NCT05664841	University of Alabama at Birmingham	Phase 2
Completed	Services to Enhance Social Functioning in Adults With Autism Spectrum Disorders NCT04788537	University of Pennsylvania	N/A
Active Not Recruiting	Behavior Therapy for Irritability in Autism NCT04654260	Yale University	N/A
Unknown	QoL and Stress in Parents of Children With Developmental Disabilities and Chronic Disease NCT03602378	University of Split, School of Medicine	—
Completed	A Study of Oxytocin for the Treatment of Social Impairment in Individuals With High Functioning Autism Spectru NCT02985749	Massachusetts General Hospital	Phase 3
Completed	Recording Facial and Vocal Emotional Productions in Children With Autism as Part of the JEMImE Project NCT03177590	Fondation Lenval	N/A
Completed	Confirmatory Efficacy Trial of Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder NCT03170453	University of Pittsburgh	N/A
Completed	Shared Decision Making to Improve Care and Outcomes for Children With Autism NCT01921244	Children's Hospital Medical Center, Cincinnati	N/A
Completed	Facilitating Employment for Youth With Autism NCT03560453	Virginia Commonwealth University	N/A
Unknown	An Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism Spectrum NCT02199925	Isaac Melamed	Phase 4
Completed	GroundsKeeper: A Qualitative Study of Applied Game-based Interactives in Special Education Programs NCT01808066	CogCubed, Corp	N/A
Unknown	Group Psychoeducational Program for Mothers of Children With High Functional Pervasive Developmental Disorders NCT01243905	Nagoya City University	Phase 2 / Phase 3
Completed	Cognitive Enhancement Therapy for Adult Autism Spectrum Disorder NCT00902798	University of Pittsburgh	N/A
Completed	Study of Aripiprazole in the Treatment of Pervasive Developmental Disorders NCT00870727	Indiana University	Phase 3
Unknown	Assessment of Factors Which Predict Improvement in Children With PDD After a Year of Integrative Therapy NCT00531830	BeerYaakov Mental Health Center	—
Completed	Placebo-Controlled Pilot Trial of Mecamylamine for Treatment of Autism Spectrum Disorders NCT00773812	Ohio State University	Phase 1
Terminated	Neurocircuitry of Autism- fMRI and Transcranial Magnetic Stimulation Studies NCT01553240	New York State Psychiatric Institute	N/A
Completed	Advanced Grandparental Age as a Risk Factor for Autism NCT00464477	University of Mississippi Medical Center	—
Active Not Recruiting	Genetic Contributions to Autism Spectrum Disorders NCT01160783	Boston Children's Hospital	—
Terminated	Evaluation and Treatment of Copper/Zinc Imbalance in Children With Autism NCT00325572	Milton S. Hershey Medical Center	Phase 1
Completed	An Open-Label Trial of Aripiprazole in Autism Spectrum Disorders NCT00308074	Cambridge Health Alliance	Phase 2
Completed	A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder. NCT00198055	Indiana University School of Medicine	Phase 2
Completed	Reliability and Validity of the MINI International Neuropsychiatric Interview for Children and Adolescents (MI NCT00579267	University of South Florida	—
Completed	Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone. NCT00399698	Ohio State University	Phase 3
Unknown	Trial of Low-Dose Naltrexone for Children With Pervasive Developmental Disorder (PDD) NCT00318162	Hadassah Medical Organization	Phase 1 / Phase 2